In addition, several statins, used in the therapy of hypercholesterinemia, hypertension, and potentially in T2DM, are also transported substrates of ABCG2, and reduced ABCG2 levels may significantly alter statin absorption and cellular statin levels (see25). This evidence concerns the gene ABCG2 and Hypertension.